Huadao Biopharma (Shanghai) Co., Ltd. announced that it will receive CNY 20 million in an equity round of funding on January 10, 2024. The transaction will include participation from returning investor, Boai NKY Medical Holdings Ltd. revising its stake from 11.18450% to 11.59690%. A "D+1 round investment agreement will be signed between the company, its shareholders and the investor.

The transaction has been approved at the eight session of Boai NKY Medical Holdings Ltd.'s fifth directorate. CNY 183,404 will be added to the registered capital of the company.